Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RALAM: Raltegravir and Lamivudine Dual Therapy in HIV
NCT02284035Phase 3Completed
- Start
- Sep 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltegravir, lamivudine in human immunodeficiency virus infection (HIV). Started Sep 2015; status: completed.
02
Drugs
raltegravirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02284035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284035.